View in EDS

Improving survival from metastatic, recurrent, or persistent cervical cancer.

Saved in:
Bibliographic Details
Title: Improving survival from metastatic, recurrent, or persistent cervical cancer.
Authors: Mileshkin LR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne and University of Melbourne, Melbourne, VIC 3000, Australia. Electronic address: linda.mileshkin@petermac.org., Manoharan S; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne and University of Melbourne, Melbourne, VIC 3000, Australia.
Source: Lancet (London, England) [Lancet] 2024 Jan 06; Vol. 403 (10421), pp. 2-4. Date of Electronic Publication: 2023 Dec 01.
Publication Type: Journal Article; Comment
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38048788
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Improving survival from metastatic, recurrent, or persistent cervical cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mileshkin+LR%22">Mileshkin LR</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne and University of Melbourne, Melbourne, VIC 3000, Australia. Electronic address: linda.mileshkin@petermac.org.<br /><searchLink fieldCode="AU" term="%22Manoharan+S%22">Manoharan S</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne and University of Melbourne, Melbourne, VIC 3000, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2024 Jan 06; Vol. 403 (10421), pp. 2-4. <i>Date of Electronic Publication: </i>2023 Dec 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38048788
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0140-6736(23)02690-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2
    Titles:
      – TitleFull: Improving survival from metastatic, recurrent, or persistent cervical cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mileshkin LR
      – PersonEntity:
          Name:
            NameFull: Manoharan S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 01
              Text: 2024 Jan 06
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1474-547X
          Numbering:
            – Type: volume
              Value: 403
            – Type: issue
              Value: 10421
          Titles:
            – TitleFull: Lancet (London, England)
              Type: main
ResultId 1